Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Retinoic acid nuclear receptor gamma variant 1 (Retinoic acid receptor gamma) (Retinoic acid receptor, gamma, isoform CRA_b) (cDNA FLJ75202, highly similar to Homo sapiens, retinoic acid receptor, gamma)

 A8K3H3_HUMAN            Unreviewed;       454 AA.
A8K3H3;
04-DEC-2007, integrated into UniProtKB/TrEMBL.
04-DEC-2007, sequence version 1.
23-MAY-2018, entry version 106.
SubName: Full=Retinoic acid nuclear receptor gamma variant 1 {ECO:0000313|EMBL:ADZ17339.1};
SubName: Full=Retinoic acid receptor gamma {ECO:0000313|EMBL:BAH02280.1};
SubName: Full=Retinoic acid receptor, gamma, isoform CRA_b {ECO:0000313|EMBL:EAW96677.1};
SubName: Full=cDNA FLJ75202, highly similar to Homo sapiens, retinoic acid receptor, gamma {ECO:0000313|EMBL:BAF83277.1};
Name=NR1B3 {ECO:0000313|EMBL:ADZ17339.1};
Synonyms=RARG {ECO:0000313|EMBL:EAW96677.1};
ORFNames=hCG_31521 {ECO:0000313|EMBL:EAW96677.1};
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF83277.1};
[1] {ECO:0000313|EMBL:EAW96677.1}
NUCLEOTIDE SEQUENCE.
PubMed=11181995; DOI=10.1126/science.1058040;
Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
"The sequence of the human genome.";
Science 291:1304-1351(2001).
[2] {ECO:0000313|EMBL:EAW96677.1}
NUCLEOTIDE SEQUENCE.
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[3] {ECO:0000313|EMBL:BAH02280.1}
NUCLEOTIDE SEQUENCE.
Nozawa A., Kobayashi T., Kodani Y., Sawasaki T., Endo Y.;
Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
[4] {ECO:0000313|EMBL:BAF83277.1}
NUCLEOTIDE SEQUENCE.
Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
"NEDO human cDNA sequencing project.";
Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
[5] {ECO:0000313|EMBL:BAH02280.1}
NUCLEOTIDE SEQUENCE.
Kobayashi T., Kodani Y., Sawasaki T., Endo Y.;
"Comprehensive DNA-binding analysis of human hormone nuclear receptors
by fluorescence correlation spectroscopy based on cell-free system.";
Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
[6] {ECO:0000313|EMBL:ADZ17339.1}
NUCLEOTIDE SEQUENCE.
TISSUE=Prostate {ECO:0000313|EMBL:ADZ17339.1};
Kaighin V.A., Martin A.L., Aronstam R.S.;
"Isolation of cDNA coding for multiple human nuclear receptor
clones.";
Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases.
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
ProRule:PRU00407, ECO:0000256|RuleBase:RU004334,
ECO:0000256|SAAS:SAAS01037405}.
-!- SIMILARITY: Belongs to the nuclear hormone receptor family.
{ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037406}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; HQ692828; ADZ17339.1; -; mRNA.
EMBL; AK290588; BAF83277.1; -; mRNA.
EMBL; AB307689; BAH02280.1; -; mRNA.
EMBL; CH471054; EAW96677.1; -; Genomic_DNA.
EMBL; CH471054; EAW96678.1; -; Genomic_DNA.
RefSeq; NP_000957.1; NM_000966.5.
UniGene; Hs.1497; -.
UniGene; Hs.733399; -.
SMR; A8K3H3; -.
DNASU; 5916; -.
GeneID; 5916; -.
KEGG; hsa:5916; -.
CTD; 5916; -.
EuPathDB; HostDB:ENSG00000172819.16; -.
PharmGKB; PA34227; -.
eggNOG; KOG3575; Eukaryota.
eggNOG; ENOG410XRZC; LUCA.
HOVERGEN; HBG005606; -.
KO; K08529; -.
OMA; NKERLFV; -.
OrthoDB; EOG091G0XCQ; -.
ChiTaRS; RARG; human.
GenomeRNAi; 5916; -.
Bgee; ENSG00000172819; -.
ExpressionAtlas; A8K3H3; baseline and differential.
GO; GO:0000790; C:nuclear chromatin; IEA:Ensembl.
GO; GO:0005654; C:nucleoplasm; IDA:HPA.
GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
GO; GO:0003708; F:retinoic acid receptor activity; IEA:Ensembl.
GO; GO:0046965; F:retinoid X receptor binding; IEA:Ensembl.
GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
GO; GO:0048048; P:embryonic eye morphogenesis; IEA:Ensembl.
GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
GO; GO:0060324; P:face development; IEA:Ensembl.
GO; GO:0002068; P:glandular epithelial cell development; IEA:Ensembl.
GO; GO:0003430; P:growth plate cartilage chondrocyte growth; IEA:Ensembl.
GO; GO:0070384; P:Harderian gland development; IEA:Ensembl.
GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
GO; GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl.
GO; GO:0031641; P:regulation of myelination; IEA:Ensembl.
GO; GO:0045637; P:regulation of myeloid cell differentiation; IEA:Ensembl.
GO; GO:0003406; P:retinal pigment epithelium development; IEA:Ensembl.
GO; GO:0060534; P:trachea cartilage development; IEA:Ensembl.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
Gene3D; 3.30.50.10; -; 1.
InterPro; IPR035500; NHR_like_dom_sf.
InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
InterPro; IPR001723; Nuclear_hrmn_rcpt.
InterPro; IPR003078; Retinoic_acid_rcpt.
InterPro; IPR001628; Znf_hrmn_rcpt.
InterPro; IPR013088; Znf_NHR/GATA.
Pfam; PF00104; Hormone_recep; 1.
Pfam; PF00105; zf-C4; 1.
PRINTS; PR01292; RETNOICACIDR.
PRINTS; PR00398; STRDHORMONER.
PRINTS; PR00047; STROIDFINGER.
SMART; SM00430; HOLI; 1.
SMART; SM00399; ZnF_C4; 1.
SUPFAM; SSF48508; SSF48508; 1.
PROSITE; PS51843; NR_LBD; 1.
PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
2: Evidence at transcript level;
DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517091};
Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037386};
Receptor {ECO:0000256|RuleBase:RU004334,
ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:BAF83277.1};
Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125}.
DOMAIN 87 162 Nuclear receptor.
{ECO:0000259|PROSITE:PS51030}.
DOMAIN 185 419 NR LBD. {ECO:0000259|PROSITE:PS51843}.
DNA_BIND 87 162 Nuclear receptor. {ECO:0000256|PROSITE-
ProRule:PRU00407}.
SEQUENCE 454 AA; 50342 MW; 1EE27B22772D4AFD CRC64;
MATNKERLFA AGALGPGSGY PGAGFPFAFP GALRGSPPFE MLSPSFRGLG QPDLPKEMAS
LSVETQSTSS EEMVPSSPSP PPPPRVYKPC FVCNDKSSGY HYGVSSCEGC KGFFRRSIQK
NMVYTCHRDK NCIINKVTRN RCQYCRLQKC FEVGMSKEAV RNDRNKKKKE VKEEGSPDSY
ELSPQLEELI TKVSKAHQET FPSLCQLGKY TTNSSADHRV QLDLGLWDKF SELATKCIIK
IVEFAKRLPG FTGLSIADQI TLLKAACLDI LMLRICTRYT PEQDTMTFSD GLTLNRTQMH
NAGFGPLTDL VFAFAGQLLP LEMDDTETGL LSAICLICGD RMDLEEPEKV DKLQEPLLEA
LRLYARRRRP SQPYMFPRML MKITDLRGIS TKGAERAITL KMEIPGPMPP LIREMLENPE
MFEDDSSQPG PHPNASSEDE VPGGQGKGGL KSPA


Related products :

Catalog number Product name Quantity
EIAAB36511 Homo sapiens,Human,NR2B3,Nuclear receptor subfamily 2 group B member 3,Retinoic acid receptor RXR-gamma,Retinoid X receptor gamma,RXRG
EIAAB33778 Homo sapiens,Human,NR1B3,Nuclear receptor subfamily 1 group B member 3,RARG,RAR-gamma,Retinoic acid receptor gamma
EIAAB36506 NR2B3,Nuclear receptor subfamily 2 group B member 3,Pig,Retinoic acid receptor RXR-gamma,Retinoid X receptor gamma,RXRG,Sus scrofa
EIAAB36508 Nr2b3,Nuclear receptor subfamily 2 group B member 3,Rat,Rattus norvegicus,Retinoic acid receptor RXR-gamma,Retinoid X receptor gamma,Rxrg
EIAAB36509 Bos taurus,Bovine,NR2B3,Nuclear receptor subfamily 2 group B member 3,Retinoic acid receptor RXR-gamma,Retinoid X receptor gamma,RXRG
EIAAB36510 Mouse,Mus musculus,Nr2b3,Nuclear receptor subfamily 2 group B member 3,Retinoic acid receptor RXR-gamma,Retinoid X receptor gamma,Rxrg
EIAAB33777 Mouse,Mus musculus,Nr1b3,Nuclear receptor subfamily 1 group B member 3,Rarg,RAR-gamma,Retinoic acid receptor gamma
EIAAB36507 Chicken,Gallus gallus,NR2B3,Nuclear receptor subfamily 2 group B member 3,Retinoic acid receptor RXR-gamma,Retinoid X receptor gamma,RXRG
PR-821 RAR-gamma-LBD (residues 150-417) Retinoic Acid Receptor, gamma-isoform, ligand binding domainhuman, recombinant, St9 insect cells 10
PR-826 RAR-gamma-LBDGST (residues 150-417) Retinoic Acid Receptor, gamma-isoform, ligand binding domainhuman, recombinant, Sf9 insect cells 10
PR-821 RAR-gamma-LBD (residues 150-417)His Retinoic Acid Receptor, gamma-isoform, ligand binding domain human, recombinant, Sf9 insect cells 10
PR-821 Proteins: RAR-gamma-LBD (residues 150-417)His Retinoic Acid Receptor, gamma-isoform, ligand binding domainhuman, recombinant, St9 insect cells 10
PR-826 RAR-gamma-LBDGST (residues 150-417) Retinoic Acid Receptor, gamma-isoform, ligand binding domain human, recombinant, Sf9 insect cells 10
PR-826 Proteins: RAR-gamma-LBDGST (residues 150-417) Retinoic Acid Receptor, gamma-isoform, ligand binding domainhuman, recombinant, Sf9 insect cells 10
201-20-4762 RARG{Homo sapiens retinoic acid receptor, gamma}rabbit.pAb 0.2ml
29-079 RXRB is a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). This receptor forms homodimers with the retinoic acid, 0.05 mg
30-088 RXRB is a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). This receptor forms homodimers with the retinoic acid, 0.05 mg
30-089 RXRB is a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). This receptor forms homodimers with the retinoic acid, 0.05 mg
SED952Hu ELISA Kit for Retinoic Acid Receptor Gamma (RARg) Homo sapiens (Human) 96T
18-003-42703 Retinoic acid receptor RXR-gamma - Retinoid X receptor gamma Polyclonal 0.1 mg Protein A
PR-755 RAR-gamma Retinoic Acid Receptor, gamma-isoformhuman, recombinant, Sf9 insect cells 5
E93952Hu ELISA Kit for Retinoic Acid Receptor Gamma (RARg) Organism: Homo sapiens (Human) 96T
A025836 Rabbit Anti-RAR gamma per Retinoic Acid Receptor gamma Ab 100ul
20-662-20102 Retinoic acid receptor gamma-1 - RAR-gamma-1 Monoclonal 0.1 ml
GTX30166 Retinoic Acid Receptor gamma _ RAR gamma [1373] 50 µg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur